cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2017-4-4-10cardiovascular-659Research ArticleАРТЕРИАЛЬНАЯ ГИПЕРТОНИЯARTERIAL HYPERTENSIONДВАДЦАТИЛЕТНИЕ ТРЕНДЫ ОЖИРЕНИЯ И АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ И ИХ АССОЦИАЦИИ В РОССИИTWENTY YEARS TRENDS OF OBESITY AND ARTERIAL HYPERTENSION AND THEIR ASSOCIATION IN RUSSIAШальнова С. А.ShalnovaS. A.

д.м.н., профессор, руководитель отдела эпидемиологии хронических неинфекционных заболеваний,

Москва

Moscow

SShalnova@gnicpm.ruДеев А. Д.DeevA. D.

к.ф.-м.н., руководитель лаборатории медицинской биостатистики,

Москва

Moscow

Баланова Ю. А.BalanovaYu. A.

к.м.н., в.н.с. лаборатории экономического анализа эпидемиологических исследований и профилактических технологий отдела,

Москва

Moscow

Капустина А. В.KapustinaA. V.

с.н.с. отдела,

Москва

Moscow

Имаева А. Э.ImaevaA. E.

к.м.н., с.н.с. отдела,

Москва

Moscow

МуромцеваГ. А.MuromtsevaG. A.

к.б.н., в.н.с. отдела,

Москва

Moscow

Киселева Н. В.KiselevaN. V.

к.м.н., в.н.с. отдела,

Москва

Moscow

Бойцов С. А.BoytsovS. A.

д.м.н., профессор, член-корр. РАН, руководитель отдела клинической кардиологии и молекулярной генетики,

Москва

Moscow

ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава РоссииРоссияNational Research Center for Preventive Medicine of the Ministry of HealthRussian Federation201720082017164410Copyright © Шальнова  С.А., Деев  А.Д., Баланова  Ю.А., Капустина  А.В., Имаева  А.Э., Муромцева Г.А., Киселева  Н.В., Бойцов  С.А., 20172017Шальнова  С.А., Деев  А.Д., Баланова  Ю.А., Капустина  А.В., Имаева  А.Э., Муромцева Г.А., Киселева  Н.В., Бойцов  С.А.Shalnova S.A., Deev A.D., Balanova Y.A., Kapustina A.V., Imaeva A.E., Muromtseva G.A., Kiseleva N.V., Boytsov S.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/659

Распространенность ожирения (Ож) и заболеваний, связанных с ним, в последние десятилетия увеличивается во всем мире, быстро достигая размеров эпидемии; становится одним из главных вызовов медицинскому сообществу и системам здравоохранения развитых стран.

Цель

Цель. Оценить тренды артериальной гипертонии (АГ) и Ож за последние 20 лет в РФ.

Материал и методы

Материал и методы. В анализ включены результаты трех исследований, выполненных по идентичному протоколу в 1993, 2003 и 2013гг при участии Государственного научно-исследовательского центра профилактической медицины. Анализировали результаты обследования 55640 мужчин и женщин в возрасте 25-64 лет. В анализ включали социально-демографические характеристики, АГ, индекс массы тела, статус курения, потребление алкоголя, частоту сердечных сокращений.

Результаты

Результаты. Частота АГ у мужчин в 1993г составляла 43,0%, снижаясь в 2003г до 36,9%, и существенно увеличилась в 2013г (47,3%). С 2003г до 2013г распространенность АГ возросла на ~20%, а распространенность Ож выросла в 2 раза за тот же период. У женщин, напротив, распространенность АГ снижалась с 1993г по 2013г; если между 1993г и 2003г снижение составило 15,4%, то между 2003г и 2013г — только 6,3%. Если в 1993г частота АГ преобладала у женщин, то в 2013г — у мужчин. Оценили зависимость АГ и Ож в каждом году наблюдения отдельно по полу в многомерной регрессионной модели. Обнаружено, что при коррекции на возраст, образование, статус курения и потребления алкоголя и повышенную частоту сердечных сокращений, вероятность АГ увеличивается с ростом частоты Ож у лиц обоего пола в 4,5-18 раз. И у мужчин, и у женщин наиболее слабая взаимосвязь между АГ и Ож выявлена в 1993г.

Заключение

Заключение. Учитывая современные тенденции, необходимо разрабатывать стратегии профилактики и лечения Ож и АГ, чтобы уменьшить развитие АГ, связанной с Ож. 

The prevalence of obesity and obesity-related disorders has been increasing in the world during last decades, reaching the level of epidemics, being one of the key challenge for medical society and healthcare systems in developed countries.

Aim

Aim. To evaluate the trends of arterial hypertension (AH) and obesity in Russia for the last 20 years.

Material and methods

Material and methods. Into analysis, the results form 3 studies included, by identical protocol, performed in 1993, 2003, 2013 with participation of the National Research Center for Preventive Medicine. The data of general investigation was analyzed, of 55640 men and women at the age 25-64 y.o. In the analysis, the social and demographic data was included, AH, body mass index, smoking, alcohol consumption, heart rate.

Results

Results. The prevalence of AH in men in 1993 was 43,0%, declining by 2003 to 36,9%, and significantly increased in 2013 (47,3%). From 2003 to 2013 the prevalence of AH increased by approx. 20%, and of obesity — raised two times during the period. In females, contrary, AH prevalence decreased from 1993 to 2013; and if during 1993-2003 gradient was 15,4%, in 2003-2013 only 6,3%. If in 1993 the prevalence of AH predominated in females, in 2013 — in males. The relation of obesity and AH was assessed for every year of observation, by gender, in multiple regression model. It was found that, if corrected by age, educational level, smoking, alcohol consumption, and increased heartrate, chance of AH increases with obesity rate increase in both genders, 4,5-18 times. In men as in women the weakest relation of AH and obesity was found in 1993.

Conclusion

Conclusion. Taken recent tendencies, it is important to develop strategies of prevention and management of obesity and AH, with the aim to decrease obesity-related AH development rate. 

ожирениеартериальная гипертониядинамикатрендыфакторы рискаobesityarterial hypertensiondynamicstrendsrisk factorsReferencesObesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/Obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med; 2017; 10.GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med; 2017; 10.Dyer AR, Elliot T. For the Intersalt CooperativeResearch Group. The Intersalt Study: relations of body mass index to blood pressure. J Hum Hypertens 1998; 3: 299-308.Dyer AR, Elliot T. For the Intersalt CooperativeResearch Group. The Intersalt Study: relations of body mass index to blood pressure. J Hum Hypertens 1998; 3: 299-308.Timpson NJ, Harbord R, Smith DG, et al. Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO/MC4R genotype. Hypertension 2009; 54: 84-90.Timpson NJ, Harbord R, Smith DG, et al. Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO/MC4R genotype. Hypertension 2009; 54: 84-90.Tesfaye F, Nawi NG, Van Minh H, et al. Association between body mass index and blood pressure across three populations in Africa and Asia. J Human Hypertens 2007; 21: 28-37.Tesfaye F, Nawi NG, Van Minh H, et al. Association between body mass index and blood pressure across three populations in Africa and Asia. J Human Hypertens 2007; 21: 28-37.Re RN. Obesity-Related Hypertension. Ochsner J 2009; 9: 133-6.Re RN. Obesity-Related Hypertension. Ochsner J 2009; 9: 133-6.Hall JE, da Silva AA, do Carmo JM, et al. Obesity-induced Hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biolog Сhem 2010; 285 (23): 17271-6.Hall JE, da Silva AA, do Carmo JM, et al. Obesity-induced Hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biolog Сhem 2010; 285 (23): 17271-6.Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment–A Position Paper of the The Obesity Society and the American Society of Hypertension. Obesity 2014; 21: 8-24.Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment–A Position Paper of the The Obesity Society and the American Society of Hypertension. Obesity 2014; 21: 8-24.Narkiewicz K. Obesity and hypertension–the issue is more complex than we thought. Nephrol Dial Transplant 2006; 21(2): 264-7.Narkiewicz K. Obesity and hypertension–the issue is more complex than we thought. Nephrol Dial Transplant 2006; 21(2): 264-7.Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue-a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002; 17: 191-5.Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue-a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002; 17: 191-5.Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10: 3621-37.Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10: 3621-37.Danaei G, Finucane MF, Lin JK, et al. on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5,4 million participants. Lancet 2011; 377: 568-77.Danaei G, Finucane MF, Lin JK, et al. on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5,4 million participants. Lancet 2011; 377: 568-77.NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 2017; 7; 389 (10064): 37-55.NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 2017; 7; 389 (10064): 37-55.NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19,2 million participants. Lancet 2016; 387 (10026): 1377-96.NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19,2 million participants. Lancet 2016; 387 (10026): 1377-96.Russia Longitudinal Monitoring survey, “RLMS-HSE”, conducted by Higher School of Economics and ZAO “Demoscope” together with Carolina Population Center, University of North Carolina at Chapel Hill and the Institute of Sociology RAS. (RLMSHSE sites: http://www.cpc.unc.edu/projects/rlms-hse, http://www.hse.ru/org/hse/rlms).Russia Longitudinal Monitoring survey, “RLMS-HSE”, conducted by Higher School of Economics and ZAO “Demoscope” together with Carolina Population Center, University of North Carolina at Chapel Hill and the Institute of Sociology RAS. (RLMSHSE sites: http://www.cpc.unc.edu/projects/rlms-hse, http://www.hse.ru/org/hse/rlms).The results of the first stage of monitoring the epidemiological situation of arterial hypertension in the Russian Federation (2003-2004), conducted within the framework of the federal target program “Prevention and treatment of arterial hypertension in the Russian Federation”. Information-statistical compilation. Moscow. 2005. 144 p. Russian (Результаты первого этапа мониторинга эпидемиологической ситуации по артериальной гипертонии в российской федерации (2003-2004 гг.), проведенного в рамках федеральной целевой программы “Профилактика и лечение артериальной гипертонии в Российской Федерации”. Информационно-статистический сборник. Москва. 2005, 144 с).The results of the first stage of monitoring the epidemiological situation of arterial hypertension in the Russian Federation (2003-2004), conducted within the framework of the federal target program “Prevention and treatment of arterial hypertension in the Russian Federation”. Information-statistical compilation. Moscow. 2005. 144 p. Russian (Результаты первого этапа мониторинга эпидемиологической ситуации по артериальной гипертонии в российской федерации (2003-2004 гг.), проведенного в рамках федеральной целевой программы “Профилактика и лечение артериальной гипертонии в Российской Федерации”. Информационно-статистический сборник. Москва. 2005, 144 с).Boitsov SA, Chazov EI, Shlyakhto EV, et al. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Preventive medicine 2013; 6: 25-34. Russian (Бойцов С.А., Чазов Е.И., Шляхто Е.В. и др. Научно-организационный комитет проекта ЭССЕ-РФ. Эпидемиология сердечно-сосудистых заболеваний в различных регионах России (ЭССЕ-РФ). Обоснование и дизайн исследования Профилактическая медицина 2013; 6; 6: 25-34).Boitsov SA, Chazov EI, Shlyakhto EV, et al. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Preventive medicine 2013; 6: 25-34. Russian (Бойцов С.А., Чазов Е.И., Шляхто Е.В. и др. Научно-организационный комитет проекта ЭССЕ-РФ. Эпидемиология сердечно-сосудистых заболеваний в различных регионах России (ЭССЕ-РФ). Обоснование и дизайн исследования Профилактическая медицина 2013; 6; 6: 25-34).Hall JE. The Kidney, hypertension and obesity Hypertension 2003; 41: 625-33.Hall JE. The Kidney, hypertension and obesity Hypertension 2003; 41: 625-33.Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134: 1-11.Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134: 1-11.Gafarov VV, Gromova EA, Gagulin IV, Gafarova AV. Effects of stress on risk of arterial hypertension in general male population of 25-64 years old: 14 years of follow up (epidemiological study on the basis of the WHO program “MONICA — PSYCHOSOCIAL”). Arterial Hypertension 2013; 1: 27-31. Russian (Гафаров В.В., Громова Е.А., Гагулин И.В., Гафарова А.В. Изучение влияния стресса на риск артериальной гипертензии в открытой популяции среди мужчин 25-64 лет (эпидемиологическое исследование на основе программы ВОЗ “Monica — Psychosocial”) Артериальная гипертензия 2013; 1: 27-31).Gafarov VV, Gromova EA, Gagulin IV, Gafarova AV. Effects of stress on risk of arterial hypertension in general male population of 25-64 years old: 14 years of follow up (epidemiological study on the basis of the WHO program “MONICA — PSYCHOSOCIAL”). Arterial Hypertension 2013; 1: 27-31. Russian (Гафаров В.В., Громова Е.А., Гагулин И.В., Гафарова А.В. Изучение влияния стресса на риск артериальной гипертензии в открытой популяции среди мужчин 25-64 лет (эпидемиологическое исследование на основе программы ВОЗ “Monica — Psychosocial”) Артериальная гипертензия 2013; 1: 27-31).Reshetnikov KV. Regional peculiarities of public health in Russia in transition period. Problemy prognozirovaniya 2001; 3: 49-58. Russian (Решетников К.В. Региональные особенности общественного здоровья в России в переходный период. Проблемы прогнозирования 2001; 3: 49-58).Reshetnikov KV. Regional peculiarities of public health in Russia in transition period. Problemy prognozirovaniya 2001; 3: 49-58. Russian (Решетников К.В. Региональные особенности общественного здоровья в России в переходный период. Проблемы прогнозирования 2001; 3: 49-58).Spruill TM. Psychosocial Stress and Hypertension. Curr Hypertens Rep 2010; 12(1): 10-6.Spruill TM. Psychosocial Stress and Hypertension. Curr Hypertens Rep 2010; 12(1): 10-6.Conen D, Glynn RJ, Ridker PM, et al. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J 2009; 30: 1378-84.Conen D, Glynn RJ, Ridker PM, et al. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J 2009; 30: 1378-84.Wang Y, Wang QJ. The prevalence of prehypertension and hypertension amongUS adults according to the new Joint National Committee guidelines. Arch Intern Med 2004; 164: 2126-34).Wang Y, Wang QJ. The prevalence of prehypertension and hypertension amongUS adults according to the new Joint National Committee guidelines. Arch Intern Med 2004; 164: 2126-34).Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13.Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13.Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-15.Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-15.Lloyd-Jones DM, Liu K, Colangelo LA, et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation 2007; 115: 1004-11.Lloyd-Jones DM, Liu K, Colangelo LA, et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation 2007; 115: 1004-11.

The authors declare that there are no conflicts of interest present.